Mayo Clinic: “Walleye Tank competition names biomedical innovation champions”

January 24, 2022

“[Herald Therapeutics], presented by David Ingbar, M.D., won in the Professionals division with the team's experimental therapy to treat acute respiratory syndrome, including COVID-induced acute respiratory syndrome, hooking a $10,000 prize. The innovation is currently undergoing phase II clinical trials.”

Read full article (Mayo Clinic)

Previous
Previous

Co-Founders Receive Award to Develop Aerosolized ThyrOxy

Next
Next

Star Tribune: “Experimental hormone therapy may speed recovery for COVID patients”